RxPG News Feed for RxPG News

Medical Research Health Special Topics World
 Asian Health
 Food & Nutrition
 Men's Health
 Mental Health
 Occupational Health
 Public Health
 Sleep Hygiene
 Women's Health
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 World Healthcare
   Latest Research
 Alternative Medicine
 Clinical Trials
 Infectious Diseases
   Ankylosing Spondylitis
   Rheumatiod Arthritis
 Sports Medicine
   Medical News
 Awards & Prizes
   Special Topics
 Odd Medical News

Last Updated: Oct 11, 2012 - 10:22:56 PM
Arthritis Channel

subscribe to Arthritis newsletter
Latest Research : Rheumatology : Arthritis

   EMAIL   |   PRINT
Role of inflammatory leukocytes in extending tissue damage

Apr 30, 2006 - 11:29:00 PM , Reviewed by: Priya Saxena
"The data in this study suggest that therapies to reduce acute influx of leukocytes into damaged cartilage should be considered in the future when treating osteochondral injuries."

[RxPG] Documented in extensive studies, backed by the anecdotal evidence of professional athletes, impact injury to joints causes degeneration of cartilage. In most cases, the eventual result is the pain, stiffness, and compromised mobility of osteoarthritis (OA). Yet, questions remain surrounding the role of the inflammatory system in the cartilage destruction following mechanical trauma.

Tissue damage typically stimulates an influx of leukocytes, white blood cells known for promoting tissue regeneration and healing--to tissue protecting organs. However leukocytes can be a double edged sword. In the May 2006 issue of Arthritis & Rheumatism researchers at Baylor College of Medicine and the Michael E DeBakey Veterans Affairs Medical Center in Houston, Texas, present the results of a study to test the hypothesis that leukocytes extend the zone of damage and cell death in cartilage after an acute injury.

The research team began with a collection of dog bones--the hind knee joints of 24 fresh young adult cadaver canines. Within one hour after death, each bone was subjected to impact injury with a metal weight, determined sufficient to cause cartilage damage without shattering the bone. A comparable collection of cadaver canine bones was preserved to serve as controls. All of the knee joints were cultured with blood leukocytes from the same dogCartilage biopsies were taken at various intervals between 12 hours and 7 days.

Among the assaulted bones, approximately half of the chondrocytes, or cartilage cells, died within 7 days. In the uninjured bones, over 90 percent of the chondrocytes survived. A surprising finding was the reduced viability of cartilage cells located well outside the vicinity of direct impact. In cartilage samples taken 6 to 9 mm from the impact site, and even in samples taken 10 mm or more from the impact site, these critical cells to tissue renewal had largely been killed off by leukocytes. The real culprit, however, was the leukocytes' generation of noxious nitric oxide (NO).

Is there a way to stop the leukocyte-mediated murders of chondrocytes? To explore this critical question, the researchers conducted more experiments on the dog bone cultures. They found that the killing of cartilage cells could be averted by desferoxamine, chemical thay=t blocks production of NO, and by anti-CD18 antibodies, which block the Velcro-like adhesion molecules that white cells use to adhere to other cells.

"Our findings have interesting clinical implications," observes the study's leading author, Dr. D. M. Green. "First, we have demonstrated that acute mechanical injury of the articular surface causes death of chondrocytes located at a distance from the site of trauma. Second, up-regulation of adhesion molecules on the affected chondrocytes allows leukocytes to adhere and to extend the zone of injury beyond the impact site. Thus, the data in this study suggest that therapies to reduce acute influx of leukocytes into damaged cartilage should be considered in the future when treating osteochondral injuries."

Publication: "Cellular Events Leading to Chondrocyte Death After Cartilage Impact Injury," D.M. Green, P.C. Noble, J.S. Ahuero, and H.H. Birdsall, Arthritis & Rheumatism, May 2006, 54:5, pp. 1509-1517.
On the web: www.interscience.wiley.com/journal/arthritis 

Advertise in this space for $10 per month. Contact us today.

Related Arthritis News
DNA-covered submicroscopic bead used to deliver genes to treat rheumatoid arthritis
Rilonacept significantly reduced acute gout flares during uric acid-lowering therapy
Advances in genetics related to ankylosing spondylitis
Is Devil's Claw the key to treating arthritis?
High birth weight - risk for rheumatoid arthritis
Matrilin-3 gene discovered to prevent onset of osteoarthritis
Rituximab halts damage to joints
Tocilizumab effective in systemic juvenile idiopathic arthritis (sJIA)
Unfavourable blood fat levels predict rheumatoid arthritis up to 10 years later
Role of inflammatory leukocytes in extending tissue damage

Subscribe to Arthritis Newsletter

Enter your email address:

For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

Contact us

RxPG Online



    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)